Author

B. Musielak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. Sala· 2 shared J. Plewka· 2 shared K. Magiera-Mularz· 2 shared I. Rodriguez· 1 shared J. Kocik· 1 shared L. Skalniak· 1 shared M. Czub· 1 shared T. A. Holak· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

D. Sala

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiophysicsbioRxivJun 12, 2020

Competition NMR for Detection of Hit/Lead Inhibitors of Protein-Protein Interactions

B. Musielak, W. Janczyk, J. Plewka…·T. Holak

The paper introduces a sensitive NMR competition assay to detect weak inhibitors of protein-protein interactions, demonstrating its use with Mdm2/X-p53 and PD-1/PD-L1 complexes.

DOI 10.3390/molecules25133017

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Cancer BiologybioRxivJun 6, 2019

CA-170 a potent small-molecule PD-L1 inhibitor or not?

B. Musielak, J. Kocik, L. Skalniak…·J. Plewka

The paper investigates whether CA-170, a small-molecule PD-L1 inhibitor, binds to hPD-L1 using biophysical assays and finds no direct binding.

DOI 10.3390/molecules24152804

humanexperimental assay

𝕏 PostBluesky